What one investor is doing now that stock valuations are at their historical highs

Matrix Asset Advisors' David Katz advocates for a nimble, dual investment approach given elevated stock valuations, with the S&P 500 trading at a forward P/E of 22x versus its 20-year average of 16x. While acknowledging the broad market's potential, Katz advises against aggressive new entries, instead recommending a rotation into undervalued sectors such as healthcare, consumer staples, small caps, and financials, which have underperformed in 2025. He emphasizes selective exposure to technology and AI, cautioning against broad market assumptions based on their performance, despite his firm's Dividend Fund outperforming with a 10.4% YTD return.

Analysis

The current equity market is characterized by elevated valuations, with the S&P 500 trading at a forward price-to-earnings ratio of approximately 22 times, significantly above its 20-year historical average of 16 times. This premium is largely driven by a concentrated rally in megacap technology stocks fueled by the artificial intelligence theme, which has propelled the index to a gain of over 8% year-to-date in 2025 despite sluggish economic growth. According to David Katz of Matrix Asset Advisors, this environment demands a cautious and selective approach rather than aggressive, broad-market entries. He advocates for a rotation into perceived pockets of undervaluation that have lagged the broader market, specifically highlighting healthcare, consumer staples, small caps, and financials. While his firm's successful Matrix Advisors Dividend Fund (MADFX), up 10.4% year-to-date, maintains large holdings in tech leaders like Microsoft and Texas Instruments, Katz expresses caution on the tech sector generally, warning that high valuations are not perpetually sustainable. He exemplifies a selective, value-oriented approach by noting Qualcomm has been 'unduly punished' and that financials have more room to run.

Key Decisions for Investors

• Given the S&P 500's extended valuation at 22x forward earnings, investors should exercise caution with new capital and avoid making large, indiscriminate allocations to broad market indices.
• Consider rebalancing portfolios by rotating capital from outperforming megacap technology stocks into undervalued sectors such as healthcare, consumer staples, and financials, which have lagged the market in 2025.
• Adopt a highly selective, 'surgical' approach to AI and technology investments, focusing on individual company fundamentals rather than chasing momentum, and be wary of companies with stretched valuations.
• Investigate potential contrarian opportunities in quality companies that have underperformed, such as the expert's example of Qualcomm, which may be 'unduly punished' relative to its long-term prospects.